| Salary History for Daniel Shooshanian | |||||
|---|---|---|---|---|---|
| Fiscal Year Campus | Title | Department | Period FTE | GF | FTR |
| 2017-18 | |||||
| UM_ANN-ARBOR | Biomedical Engineering Tech Sr | UMH Clinical Engineering Svcs | 12-Month 1.00 | $0 | $70,500 |
| Change from last Fiscal Year: | 0.00 % | ||||
| 2018-19 | |||||
| UM_ANN-ARBOR | BIOMED ENG TECH CLIN ENG DIS | UMH Clinical Engineering Svcs | 12-Month 1.00 | $0 | $85,155 |
| Change from last Fiscal Year: | 20.79 % | ||||
| 2019-20 | |||||
| UM_ANN-ARBOR | BIOMED ENG TECH CLIN ENG DIS | UMH Clinical Engineering Svcs | 12-Month 1.00 | $0 | $87,714 |
| Change from last Fiscal Year: | 3.00 % | ||||
| 2020-21 | |||||
| UM_ANN-ARBOR | BIOMED ENG TECH CLIN ENG DIS | UMH Clinical Engineering Svcs | 12-Month 1.00 | $0 | $90,355 |
| Change from last Fiscal Year: | 3.01 % | ||||
| 2021-22 | |||||
| UM_ANN-ARBOR | BIOMED ENG TECH CLIN ENG DIS | MM Clinical Engineering Svcs | 12-Month 1 | $0 | $93,059 |
| Change from last Fiscal Year: | 2.99 % | ||||
| 2022-23 | |||||
| UM_ANN-ARBOR | BIOMED ENG TECH CLIN ENG DIS | MM Clinical Engineering Svcs | 12-Month 1.00 | $0 | $95,846 |
| Change from last Fiscal Year: | 3.00 % | ||||
| 2023-24 | |||||
| UM_ANN-ARBOR | BIOMED ENG TECH CLIN ENG DIS | MM Clinical Engineering Svcs | 12-Month 1 | $0 | $100,630 |
| Change from last Fiscal Year: | 4.99 % | ||||
| 2024-25 | |||||
| UM_ANN-ARBOR | BIOMED ENG TECH CLIN ENG DIS | MM Clinical Engineering Svcs | 12-Month 1.00 | $0 | $104,666 |
| Change from last Fiscal Year: | 4.01 % | ||||
| 2025-26 | |||||
| UM_ANN-ARBOR | BIOMED ENG TECH CLIN ENG DIS | MM Clinical Engineering Svcs | 12-Month 1.00 | $0 | $108,846 |
| Change from last Fiscal Year: | 3.99 % | ||||
| Fiscal Year Campus | Title | Department | Period FTE | GF | FTR |
| Random Names from University of Michigan |
|---|
| Canter, Amanda |
| Tewari, Ambuj |
| Zilka, Gabrielle |
| Jonatzke, Kira |
| Nisbett, Sarah |
| McGann, Pj |
| Kovala, Elizabeth |
| Washabaugh, Peter D |
| Chartier, Christopher J |
| Simko, Tyler Mark |